12 research outputs found
THE EFFECTS OF ANTI-CD20 THERAPY ON SUSCEPTIBILITY TO PNEUMOCYSTIS INFECTION AND THE CD4+ T-CELL SIGNALS THAT MEDIATE CLEARANCE
Pneumocystis is an opportunistic fungal pathogen that presents as a pulmonary pneumonia. Originally characterized as an AIDs-defining illness, Pneumocystis has now reemerged in non-HIV immunocompromised patients. It has been shown that Pneumocystis prophylaxis of can reduce the incidence of infection, severity of disease, and mortality rate in immunocompromised patients. However, prophylaxis is relatively toxic, and only prescribed to defined at risk populations. Anti-CD20 was originally a therapy for B-cell non-Hodgkin lymphomas, but now it’s also used to treat hematological malignancies, autoimmune diseases, and post-transplant lymphoproliferative disease. Studies have shown that up to 30% of patients receiving anti-CD20 antibodies developed Pneumocystis pneumonia, however, many of these patients were also on concomitant immunosuppressive drugs which complicates any analyses of clinical studies. Thus, we generated a murine model of anti-CD20 therapy, and demonstrated treatment does induce susceptibility to Pneumocystis infection. This correlated to an overall decrease in immune response, but more specifically a loss in CD4+ T-cell mediated protection.
The predominant factor required for immunity against Pneumocystis infection is the presence of CD4+ T-cells. This has been validated several times over by clinical data and experimental animal models. Early on, studies have examined the role of T helper 1 (Th1), T helper 2 (Th2), and T helper 17 (Th17) cells. To briefly summarize these studies, Th1, Th2, and Th17 cells can all be detected in the lung during infection, however, removal of their classically defined effector molecules only delayed clearance or had no effect. We examined the importance of each subset of T helper cells by deleting the Stat transcription factors that mediated differentiation. We found that specifically Stat3 was required, however, it was independent of IL-17 and IL-23 signals. We also identified IL-21 as a key cytokine required to mediate clearance. Using a variety of approaches, we determined that GM-CSF and IL-22 play important roles during Pneumocystis infection. GM-CSF+ CD4+ T-cells are critical for T-cell mediated clearance, however, it alone is not sufficient. While IL-22, although not required, was sufficient to reduce burden in IL-21 receptor knockout mice. These data suggest a model of clearance, requiring non-classical T helper cell function
Aspergillus fumigatus preexposure worsens pathology and improves control of Mycobacterium abscessus pulmonary infection in mice
ABSTRACT
Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. Mutations in this chloride channel lead to mucus accumulation, subsequent recurrent pulmonary infections, and inflammation, which, in turn, cause chronic lung disease and respiratory failure. Recently, rates of nontuberculous mycobacterial (NTM) infections in CF patients have been increasing. Of particular relevance is infection with
Mycobacterium abscessus
, which causes a serious, life-threatening disease and constitutes one of the most antibiotic-resistant NTM species. Interestingly, an increased prevalence of NTM infections is associated with worsening lung function in CF patients who are also coinfected with
Aspergillus fumigatus
. We established a new mouse model to investigate the relationship between
A. fumigatus
and
M. abscessus
pulmonary infections. In this model, animals exposed to
A. fumigatus
and coinfected with
M. abscessus
exhibited increased lung inflammation and decreased mycobacterial burden compared with those of mice infected with
M. abscessus
alone. This increased control of
M. abscessus
infection in coinfected mice was mucus independent but dependent on both transcription factors T-box 21 (Tbx21) and retinoic acid receptor (RAR)-related orphan receptor gamma t (RORγ-t), master regulators of type 1 and type 17 immune responses, respectively. These results implicate a role for both type 1 and type 17 responses in
M. abscessus
control in
A. fumigatus
-coinfected lungs. Our results demonstrate that
A. fumigatus
, an organism found commonly in CF patients with NTM infection, can worsen pulmonary inflammation and impact
M. abscessus
control in a mouse model.
</jats:p
Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation
Interleukin-17 (IL-17) and IL-17 receptor (IL-17R) signaling are essential for regulating mucosal host defense against many invading pathogens. Commensal bacteria, especially segmented filamentous bacteria (SFB), are a crucial factor that drives T helper 17 (Th17) cell development in the gastrointestinal tract. In this study, we demonstrate that Th17 cells controlled SFB burden. Disruption of IL-17R signaling in the enteric epithelium resulted in SFB dysbiosis due to reduced expression of α-defensins, Pigr and Nox1. When subjected to experimental autoimmune encephalomyelitis, IL-17R signaling deficient mice demonstrated earlier disease onset and worsened severity that was associated with increased intestinal Csf2 expression and elevated systemic GM-CSF cytokine concentrations. Conditional deletion of IL-17R in the enteric epithelium demonstrated that there was a reciprocal relationship between the gut microbiota and enteric IL-17R signaling that controlled dysbiosis, constrained Th17 development, and regulated the susceptibility to autoimmune inflammation
Immunology of Cryptococcal Infections: Developing a Rational Approach to Patient Therapy
Cryptococcal meningoencephalitis is responsible for upwards of 15% of HIV-related deaths worldwide and is currently the most common cause of non-viral meningitis in the US, affecting both previously healthy and people with immune suppression caused by cancer chemotherapy, transplantation, and biologic therapies. Despite a continued 30–50% attributable mortality, recommended therapeutic strategies have remained largely unchanged since the 1950s. Recent murine models and human studies examining the role of the immune system in both susceptibility to the infection as well as host damage have begun to influence patient care decisions. The Damage Framework Response, originally proposed in 1999, was recently used to discuss dichotomous etiologies of host damage in cryptococcal disease. These include patients suffering microbiological damage with low host immunity (especially those immunosuppressed with HIV) and those having low (live) microbiological burden but high immune-mediated damage (HIV-related immune reconstitution syndrome and non-HIV-related postinfectious inflammatory response syndrome). Cryptococcal disease in previously healthy hosts, albeit rare, has been known for a long time. Immunophenotyping and dendritic cell-T cell signaling studies on cerebral spinal fluid of these rare patients reveal immune capacity for recognition and T-cell activation pathways including increased levels of HLA-DR and CD56. However, despite effective T-cell signals, brain biopsy and autopsy specimens demonstrated an M2 alternative macrophage polarization and poor phagocytosis of fungal cells. These studies expand the paradigm for cryptococcal disease susceptibility to include a prominent role for immune-mediated damage and suggest a need for careful individual consideration of immune activation during therapy of cryptococcal disease in diverse hosts
Pneumocystis-Driven Inducible Bronchus-Associated Lymphoid Tissue Formation Requires Th2 and Th17 Immunity
Inducible bronchus-associated lymphoid tissue (iBALT) is an ectopic lymphoid structure composed of highly organized T cell and B cell zones that forms in the lung in response to infectious or inflammatory stimuli. Here, we develop a model for fungal-mediated iBALT formation, using infection with Pneumocystis that induces development of pulmonary lymphoid follicles. Pneumocystis-dependent iBALT structure formation and organization required CXCL13 signaling. Cxcl13 expression was regulated by interleukin (IL)-17 family members, as Il17ra−/−, Il17rb−/−, and Il17rc−/− mice failed to develop iBALT. Interestingly, Il17rb−/− mice have intact Th17 responses, but failed to generate an anti-Pneumocystis Th2 response. Given a role for Th2 and Th17 immunity in iBALT formation, we demonstrated that primary pulmonary fibroblasts synergistically upregulated Cxcl13 transcription following dual stimulation with IL-13 and IL-17A in a STAT3/GATA3-dependent manner. Together, these findings uncover a role for Th2/Th17 cells in regulating Cxcl13 expression and provide an experimental model for fungal-driven iBALT formation
Recommended from our members
Murine models of Pneumocystis infection recapitulate human primary immune disorders
Despite the discovery of key pattern recognition receptors and CD4+ T cell subsets in laboratory mice, there is ongoing discussion of the value of murine models to reflect human disease. Pneumocystis is an AIDS-defining illness, in which risk of infection is inversely correlated with peripheral CD4+ T cell counts. Due to medical advances in the control of HIV, the current epidemiology of Pneumocystis infection is predominantly due to primary human immunodeficiencies and immunosuppressive therapies. To this end, we found that every human genetic immunodeficiency associated with Pneumocystis infection that has been tested in mice recapitulated susceptibility. For example, humans with a loss-of-function IL21R mutation are severely immunocompromised. We found that IL-21R, in addition to CD4+ T cell intrinsic STAT3 signaling, were required for generating protective antifungal class-switched antibody responses, as well as effector T cell-mediated protection. Furthermore, CD4+ T cell intrinsic IL-21R/STAT3 signaling was required for CD4+ T cell effector responses, including IL-22 production. Recombinant IL-22 administration to Il21r-/- mice induced the expression of a fungicidal peptide, cathelicidin antimicrobial peptide, which showed in vitro fungicidal activity. In conclusion, SPF laboratory mice faithfully replicate many aspects of human primary immunodeficiency and provide useful tools to understand the generation and nature of effector CD4+ T cell immunity
Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation
Interleukin-17 (IL-17) and IL-17 receptor (IL-17R) signaling are essential for regulating mucosal host defense against many invading pathogens. Commensal bacteria, especially segmented filamentous bacteria (SFB), are a crucial factor that drives T helper 17 (Th17) cell development in the gastrointestinal tract. In this study, we demonstrate that Th17 cells controlled SFB burden. Disruption of IL-17R signaling in the enteric epithelium resulted in SFB dysbiosis due to reduced expression of α-defensins, Pigr and Nox1. When subjected to experimental autoimmune encephalomyelitis, IL-17R signaling deficient mice demonstrated earlier disease onset and worsened severity that was associated with increased intestinal Csf2 expression and elevated systemic GM-CSF cytokine concentrations. Conditional deletion of IL-17R in the enteric epithelium demonstrated that there was a reciprocal relationship between the gut microbiota and enteric IL-17R signaling that controlled dysbiosis, constrained Th17 development, and regulated the susceptibility to autoimmune inflammation